1990
DOI: 10.1038/ki.1990.69
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy of hepatic computed tomography to detect iron overload in chronic hemodialysis

Abstract: The diagnostic efficacy of hepatic computed tomography density (HCTD) in comparison with serum ferritin for the detection of iron overload was investigated in uremic patients on maintenance hemodialysis (HD) and in patients with idiopathic hemochromatosis (IHC). Ten IHC patients, 38 HD patients and 40 healthy subjects underwent the CT scanning of the liver and determination of percent saturation of transferrin, serum ferritin concentration and HLA typing. Liver iron content was determined by histochemical grad… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0
1

Year Published

1994
1994
2021
2021

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 23 publications
(11 citation statements)
references
References 38 publications
0
10
0
1
Order By: Relevance
“…Iron excess in the liver parenchyma causes an increase in CT attenuation of the liver [2][3][4][5][6]. The characteristic radiological finding is a "white liver" in unenhanced CT scans with a diffuse increase in liver density above 70 HU (Fig.…”
Section: Visceral Involvementmentioning
confidence: 94%
“…Iron excess in the liver parenchyma causes an increase in CT attenuation of the liver [2][3][4][5][6]. The characteristic radiological finding is a "white liver" in unenhanced CT scans with a diffuse increase in liver density above 70 HU (Fig.…”
Section: Visceral Involvementmentioning
confidence: 94%
“…The advent of recombinant human erythropoietin in the early 1990s represented a therapeutic revolution which allowed anemia and iron overload to be treated simultaneously by inducing both massive mobilization of iron stores and effective phlebotomy by partial letting of the extracorporeal circuit at the end of the dialysis sessions in patients who had been rendered nonanemic [47]. The same period saw the first successful use of quantitative computed tomography, the first noninvasive radiological tool, for the diagnosis of hemodialysis-associated hemosiderosis and for monitoring liver iron stores [48]. The full-blown clinical picture of hemodialysis-associated hemosiderosis disappeared from dialysis centers in industrialized countries at least 3 decades ago but may still occur in emerging countries where ESAs are not available [3].…”
Section: Intravenous Iron Products In Dialysis Patientsmentioning
confidence: 99%
“…At the beginning of the 1990s, the advent of recombinant human erythropoïetin allowed simultaneous treatment of anemia and iron overload by allowing massive mobilization of iron stores and effective phlebotomy (by partial letting of the extracorporeal circuit) at the end of dialysis sessions in patients rendered non anemic [34], together with the first successful use of non invasive radiological tools (liver quantitative computer tomography) to diagnose hemodialysis-associated hemosiderosis and to monitor iron stores [35].…”
Section: Hemodialysis-associated Hemosiderosis In the Pre-esa Eramentioning
confidence: 99%